Shanmuganathan Chandrakasan
Medical Director of Immune Dysregulation/ · Emory University School of Medicine
Credentials: · · ·
History
- Present
Immune Dysregulation/ · Emory University School of Medicine
Research
Blood · 2017 · 513 citations
Blood · 2018 · 352 citations
Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment
Review · The Journal of Pediatrics · 2013 · First of 2 authors · Corresponding · 176 citations
- SP
24 papers
- JL
22 papers

22 papers

21 papers

20 papers
- TT
20 papers

19 papers

19 papers · 5 as a fellow
Grants
- 2024–2026
National Heart, Lung, and Blood Institute · R03
Contact PI · $234.8K · Emory University
- 2019–2025
Targeted Non-Genotoxic Hematopoietic Stem Cell Transplant Conditioning Approach
National Heart, Lung, and Blood Institute · K08
Contact PI · $815.4K · Emory University
Clinical trials
- 2017–2025
JSP191 Antibody Targeting Conditioning in SCID Patients
Principal investigator · Terminated · Phase 1, Phase 2
Jasper Therapeutics, Inc.
- 2026–2031
- 2023–2028
Site PI · Recruiting · Phase 2, Phase 3
Cabaletta Bio
- 2018–2028
Site PI · Recruiting · Phase 1, Phase 2
David Williams





